Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Patient Conversation Media
AddedFeb 16, 2024
UpdatedJun 18, 2026
Patient Conversation Media

Patient Conversation Media

PCMi, an eHealth media company, streamlines patient-provider communications, prescribes actionable health info, and reduces healthcare costs.

HQ
Austin, TX, US
Founded
2009
Overview
Compare
Fundraising
Employees

Patient Conversation Media, Inc. (PCMi) is an eHealth media company dedicated to enhancing patient-provider communications and reducing healthcare costs. Through its consumer-centric 1-800-Brands, PCMi enables health providers to manage patient conversations effectively, maximizing appointment productivity. The company also publishes the dailyRx Information Network, which produces, aggregates, and syndicates trusted health and medication news and videos.

PCMi has made significant strides in the eHealth sector by providing actionable health information and improving communication efficiency between patients and providers. Its innovative approach has positively impacted healthcare delivery, making it more efficient and patient-focused.

Patient Conversation Media - Similar Companies

Patient Communicator logo

Patient Communicator

PatientPoint logo

PatientPoint

patientpoint.com

PatientWisdom logo

PatientWisdom

patientwisdom.com

MedChat logo

MedChat

medchatapp.com

medEchat logo

medEchat

medechat.com

PatientFocus logo

PatientFocus

patientfocus.com

Playback Health logo

Playback Health

playbackhealth.com

Patient Premier logo

Patient Premier

patientpremier.com

VocoMD logo

VocoMD

DocTalk logo

DocTalk

getdoctalk.com

Push Health logo

Push Health

pushhealth.com

MedRespond logo

MedRespond

medrespond.com

MDconnectME logo

MDconnectME

Eloquence Communications logo

Eloquence Communications

Health-e-MedRecord logo

Health-e-MedRecord

Patient Conversation Media - Quick Facts

Who are Patient Conversation Media's competitors?

Companies similar to Patient Conversation Media include Patient Communicator, PatientPoint, PatientWisdom and MedChat.

When was Patient Conversation Media founded?

Patient Conversation Media was founded in 2009.

Where is Patient Conversation Media's headquarters located?

Patient Conversation Media's headquarters is located in Austin, TX, US.

When was Patient Conversation Media's last funding round?

Patient Conversation Media's most recent funding round was for $350k (USD) in April 2013.

How much has Patient Conversation Media raised to-date?

As of Apr 23, 2013, Patient Conversation Media has raised a total of $1.3M (USD).

How many employees does Patient Conversation Media have?

Patient Conversation Media has 33 employees as of Feb 5, 2024.

Patient Conversation Media - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Advertising
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Health Information
  • Media
Tags
  • Healthtech
NAICS
  • 513100Newspaper, Periodical, Book, and Directory Publishers
  • 510000Information
  • 513000Publishing Industries
SIC
  • 7300Business Services
  • 7310Advertising
  • 7313Radio, Television, And Publishers' Advertising Representatives
Show 5 more industry codes
NAICS
  • 513110Newspaper Publishers
SIC
  • 2700Printing, Publishing, And Allied Industries
  • 2710Newspapers: Publishing, Or Publishing And Printing
  • 2711Newspapers: Publishing, Or Publishing And Printing
  • 2740Miscellaneous Publishing